Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions

BACKGROUND: Combining targeted biopsy (TB) with systematic biopsy (SB) is currently recommended as the first-line biopsy method by the European Association of Urology (EAU) guidelines in patients diagnosed with prostate cancer (PCa) with an abnormal magnetic resonance imaging (MRI). The combined SB...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Chen, Tong, Wang, Meng, Chen, Hanbing, Wang, Caishan, Liu, Peiqing, Liu, Songtao, Luo, Jing, Ma, Qi, Xu, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697444/
https://www.ncbi.nlm.nih.gov/pubmed/34949183
http://dx.doi.org/10.1186/s12894-021-00949-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697444/
https://www.ncbi.nlm.nih.gov/pubmed/34949183
http://dx.doi.org/10.1186/s12894-021-00949-7

Ejemplares similares